These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 14108676)

  • 1. [CONSIDERATIONS ON RESULTS OBTAINED FROM EXCHANGE TRANSFUSION TREATMENT OF HEMOLYTIC DISEASE OF THE NEWBORN FROM RH AND ABO FACTORS].
    BABINI B; SCORZA PA
    Minerva Pediatr; 1963 Nov; 15():1240. PubMed ID: 14108676
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of exchange transfusion therapy in hemolytic disease of the newborn].
    NOWOSAD K; BARON A; PODOLAK O
    Zentralbl Gynakol; 1962 Sep; 84():1430-6. PubMed ID: 13939172
    [No Abstract]   [Full Text] [Related]  

  • 3. RH FACTOR. INTRODUCTION: HEMOLYTIC DISEASE OF THE NEWBORN.
    BANNER EA
    Clin Obstet Gynecol; 1964 Dec; 10():906-15. PubMed ID: 14234043
    [No Abstract]   [Full Text] [Related]  

  • 4. [RESULTS OBTAINED IN THE TREATMENT OF MATERNAL-FETAL ABO AND RH INCOMPATIBILITY].
    GANDOLFOCARAMELLO MT; MARTINETTO G
    Minerva Pediatr; 1963 Nov; 15():1267-71. PubMed ID: 14108686
    [No Abstract]   [Full Text] [Related]  

  • 5. [IMMEDIATE AND LATE RESULTS OF HEMOLYTIC DISEASE OF THE NEWBORN FROM RH AND ABO FACTORS].
    DICAGNO L; LANGE MM; CASTELLO D
    Minerva Pediatr; 1963 Nov; 15():1207-35. PubMed ID: 14108674
    [No Abstract]   [Full Text] [Related]  

  • 6. [HEMOLYTIC DISEASE OF THE NEWBORN].
    MEDINAAGUILAR R
    Ginecol Obstet Mex; 1964; 19():205-16. PubMed ID: 14195481
    [No Abstract]   [Full Text] [Related]  

  • 7. [IMMEDIATE EFFECTS OF CORTICOSTEROID THERAPY IN GRAVE JAUNDICE OF THE NEWBORN].
    RAZON S; MAZZOLA G
    Pediatria (Napoli); 1964 Aug; 72():719-30. PubMed ID: 14190802
    [No Abstract]   [Full Text] [Related]  

  • 8. [TREATMENT OF HEMOLYTIC DISEASE OF THE NEWBORN].
    LARDINOIS R
    Rev Med Liege; 1963 Oct; 18():648-53. PubMed ID: 14097936
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE SELECTION OF BLOOD FOR EMERGENCY TRANSFUSIONS].
    TENCZAR FJ; MATSON GA
    Sangre (Barc); 1963; 42():312-8. PubMed ID: 14112680
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 12. [EXCHANGE TRANSFUSION WITH RH-POSITIVE BLOOD IN HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY RHESUS FACTOR INCOMPATIBILITY. EXPERIENCE OF THE HOSPITAL DE CARABINEROS].
    OYARCE P; HERNANDEZ R; APARA J; TORT A
    Minerva Pediatr; 1964 May; 16():619-23. PubMed ID: 14169278
    [No Abstract]   [Full Text] [Related]  

  • 13. PROBLEMS IN THE MANAGEMENT OF ERYTHROBLASTOSIS FETALIS. III. FURTHER OBSERVATIONS ON CASES WITH UNUSUAL SEROLOGIC AND CLINICAL FINDINGS.
    WIENER AS; BRANCATO GJ; WEXLER IB
    Exp Med Surg; 1964; 22():1-12. PubMed ID: 14164354
    [No Abstract]   [Full Text] [Related]  

  • 14. [INFLUENCE OF THE ABO BLOOD GROUP SYSTEM ON THE OCCURRENCE OF HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY RH INCOMPATIBILITY].
    BOSSI E
    Helv Paediatr Acta; 1964 Jun; 19():34-41. PubMed ID: 14189841
    [No Abstract]   [Full Text] [Related]  

  • 15. [OUR THERAPEUTIC EXPERIENCE WITH EXCHANGE TRANSFUSION IN GRAVE JAUNDICE OF THE NEWBORN].
    MAZZOLA G
    Pediatria (Napoli); 1964 Aug; 72():689-98. PubMed ID: 14190799
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE UNDERSTANDING OF HEMOLYTIC DISEASES NEWBORN: OF THE RESULTS OF SEROLOGICAL STUDIES].
    BOETTGER JT
    Munch Med Wochenschr; 1964 Dec; 106():2332-6. PubMed ID: 14337878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mortality of newborn infants with hemolytic disease treated by exchange transfusion. Analysis of 524 cases].
    Polácek K
    Cesk Pediatr; 1967 Dec; 22(12):1059-66. PubMed ID: 4965949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of determination of the blood groups and Rh factors after exchange transfusions in newborn infants].
    Avdeeva RA; Kopp VD; Vasil'eva AF
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):7-12. PubMed ID: 417341
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications and mortality of exchange transfusion in the newborn. (Considerations on 777 interventions)].
    Mencarini L; Ottaviano S; Marzetti G; Ermini M
    Riv Clin Pediatr; 1967; 80(4):70-80. PubMed ID: 4974289
    [No Abstract]   [Full Text] [Related]  

  • 20. [DIAGNOSIS, SEROLOGIC PROGNOSIS AND THERAPY OF FETO-MATERNAL IMMUNIZATION].
    ANDRE A
    Rev Med Liege; 1963 Oct; 18():641-5. PubMed ID: 14097934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.